New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For DELL;ADNC;MRK;TSN;CTRP;GDOT;VVUS;NFLX;MCK;MAT;LTM;ALKS;ELN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | all recent news | >>
November 25, 2014
09:39 EDTNFLXActive equity options trading
Subscribe for More Information
07:24 EDTNFLXNetflix downgraded to Hold from Buy at Stifel
Stifel assumed coverage on Netflix with a Hold rating from a Buy rating. The firm views risk/reward as balanced and would become more constructive on shares in the low-$300 range.
06:21 EDTNFLXNetflix trends not showing improvement yet in Q4, says Citigroup
Subscribe for More Information
06:00 EDTNFLXStocks with implied volatility below IV index mean; NFLX BHI
Subscribe for More Information
November 24, 2014
16:00 EDTNFLXOptions Update; November 24, 2014
Subscribe for More Information
09:39 EDTNFLXActive equity options trading
Subscribe for More Information
08:31 EDTMCKOmnicare, McKesson expand distribution agreement
Omnicare (OCR) and McKesson Corporation (MCK) announced the signing of an expanded agreement to include the sourcing and distribution of branded, specialty and generic pharmaceuticals. The new five year agreement, which extends through December 2019, creates efficiencies for both companies by leveraging the strength of Omnicare as the nationís largest institutional pharmacy and a leading specialty pharmaceutical services provider and McKesson as a global leader in pharmaceutical sourcing and supply chain management. Omnicare noted that it believes the benefits of its new sourcing strategy will be a key driver in enabling it to generate a low double-digit adjusted cash EPS growth rate in 2015.
08:02 EDTMRKMerck submits NDA to Japanese PMDA for Omarigliptin
Merck announced that the company has submitted a new drug application for omarigliptin, its investigational once-weekly DPP-4 inhibitor for the treatment of type 2 diabetes, to the Japanese Pharmaceuticals and Medical Devices Agency. The new drug application for omarigliptin is based on a comprehensive clinical development program in Japan. The results from the first Phase 3 study of omarigliptin, conducted in Japan, were presented recently at the 50th European Association for the Study of Diabetes Annual Meeting. Japan is the first country with a regulatory filing for omarigliptin. Worldwide, Merck is supporting omarigliptin with a clinical development program that includes nine Phase 3 clinical trials involving approximately 7,500 patients with type 2 diabetes in support of planned regulatory filings.
07:33 EDTMRKMerck, NewLink enter licensing, collaboration agreement for Ebola vaccine
Merck (MRK) and NewLink Genetics (NLNK) announced that they have entered into an exclusive worldwide license agreement to research, develop, manufacture, and distribute NewLink's investigational rVSV-EBOV vaccine candidate. Under the terms of the agreement, Merck will be granted the exclusive rights to the rVSV-EBOV vaccine candidate as well as any follow-on products. The vaccine candidate is under an exclusive licensing arrangement with a wholly-owned subsidiary of NewLink Genetics. Under these license arrangements, the PHAC retains non-commercial rights pertaining to the vaccine candidate. Phase I clinical trials of the rVSV-EBOV vaccine are now underway at the Walter Reed Army Institute of Research and the NIAID at the NIH. Additional Phase I studies are underway or planned to begin in the near future at clinical research centers in Switzerland, Germany, Kenya, and Gabon in a World Health Organization-coordinated effort, and in Canada by the Canadian Immunization Research Network.
07:33 EDTMCKBrean Capital to hold a summit
Subscribe for More Information
07:31 EDTMRKMerck, NewLink Genetics enter into agreement for investigational Ebola vaccine
Subscribe for More Information
November 21, 2014
16:34 EDTCTRPRoyal Caribbean, Ctrip.com announce joint venture through SkySea Cruises
Subscribe for More Information
12:31 EDTNFLXAmazon.com looking to launch new video streaming service, NY Post says
Subscribe for More Information
10:01 EDTMATOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:39 EDTMATMattel coverage resumed with a Neutral at Goldman
Subscribe for More Information
07:51 EDTMRKBofA/Merrill biotech analysts hold analyst/industry conference call
Subscribe for More Information
06:17 EDTCTRPCtrip.com initiated with an Overweight at HSBC
Subscribe for More Information
06:01 EDTNFLXStocks with implied volatility below IV index mean; BHI NFLX
Subscribe for More Information
November 20, 2014
14:52 EDTNFLXNetflix to discuss future of TV with top industry executives, Re/code says
Netflix is holding a summit about the future of TV next month, according to Re/code The company invited many of the leading executives from the TV and film industries to the private event, the website added. Reference Link
13:31 EDTLTMDillard's rallies after hedge fund pushes REIT option
Subscribe for More Information
<< 1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use